Katalysen Ventures

Logotype for Katalysen Ventures
Ticker/ISIN
KAV
SE0016798045
Marknad/Land
Spotlight
Sweden

Om Katalysen Ventures

Katalysen Ventures är ett svenskt investeringsbolag, eller en så kallad ”Venture Developer”. Verksamheten går ut på att investera kunskap, tid och kapital i kundbolag i tidiga skeden. Flertalet av dessa kundbolag har kopplingar till fintech, och en majoritet utvecklar digitala plattformar. Mot detta erhåller Katalysen Ventures, utöver ett direkt ägande vid kapitalinjektioner, även teckningsoptioner kundbolagen. Bolaget har kontor i Stockholm samt Geneve.

Senaste sammanfattade pressmeddelande från Katalysen Ventures

Aktieägare som vill delta i Katalysen Ventures bolagsstämma måste vara registrerade i aktieboken hos Euroclear Sweden AB senast den 5 november 2025. Anmälan om deltagande bör ske senast den 7 november 2025 via post eller e-post. För aktieägare med förvaltarregistrerade aktier krävs rösträttsregistrering senast den 7 november 2025. Aktieägare som representeras av ombud måste utfärda en skriftlig fullmakt. En dagordning för stämman inkluderar bland annat val av ordförande och beslut om bemyndigande för styrelsen att genomföra emissioner. Styrelsen föreslår att de får rätt att emittera aktier eller teckningsoptioner upp till 1 243 067 stycken, vilket motsvarar en maximal utspädning om cirka 12 procent. Förslaget kräver två tredjedelars majoritet för att godkännas. Aktieägare har rätt att ställa frågor under stämman. Fullständiga förslag och handlingar kommer att finnas tillgängliga två veckor före stämman. Det finns 9 115 826 utestående aktier och röster i bolaget, med ytterligare 493 615 aktier under registrering. Personuppgifter hanteras enligt Euroclears integritetspolicy. För mer information kan CEO Anders Dahlgren kontaktas.
Valega collaborates with financial institutions, advisory firms, and law enforcement across Europe, North America, and Asia, working with entities like Softronic, Europol, and North American government agencies. It has developed a comprehensive crypto intelligence database over six years, offering a competitive advantage. Valega's compliance architecture integrates transaction monitoring, risk intelligence, forensics, auditability, and reporting, aiming to replace fragmented systems and become a strategic partner in finance. Digital assets are increasingly entering the regulated financial system. Tobias Mathiasen from Katalysen notes that financial institutions seek partners with technical and regulatory expertise. Valega is well-positioned to meet these needs as tokenized assets are projected to grow significantly. Valega has been involved in major investigations and regulatory framework contributions, gaining recognition from international bodies. Valega is expanding commercially in the UK, Germany, and North America, with revenues doubling annually. Its goal is to lead in digital asset governance, risk, and compliance within two years. Peter Almberg of Katalysen highlights Valega's strong data foundation and trusted partnerships, which attract institutions entering the digital asset space. Valega is a core investment for Katalysen, comprising over 70% of its portfolio value, with Katalysen owning more than 20% of Valega. Katalysen supports its investments with capital, expertise, and strategic guidance for long-term value creation.
Katalysen's board of directors has decided to conduct a directed share issue, deviating from shareholders' preferential rights, by issuing 493,615 new shares to eight Swedish and international partners. The subscription price is set at SEK 6, which is approximately a 10.04% discount compared to the volume-weighted average price from mid-September to late October. The board believes this price reflects current market conditions and demand. Due to market volatility, the costs associated with a rights issue would likely surpass the discount value of this directed issue. Payment is due by October 28, 2025, with the board retaining the option to extend the deadline. The board chose a directed issue over a rights issue, as recent rights issues have struggled due to market conditions, and subscription levels have been low. The board believes this approach is more time- and cost-effective for the company's development. As a result, the total number of shares will increase from 9,115,826 to 9,609,441, and share capital will rise from SEK 1,185,057.38 to SEK 1,249,227.33, causing a dilution of approximately 5% for existing shareholders.
S4DX is a medtech company focused on improving the pre-analytical phase of blood sample diagnostics, providing a hybrid software and hardware solution that ensures full traceability and integrity of samples from collection to laboratory analysis. Recently, S4DX began operations in the UK by shipping 180 SmartTubes to a new partner, marking the start of its UK expansion. This move aligns with the UK's shift towards stricter quality standards, such as ISO 15189:2022, which demands comprehensive traceability in the pre-analytical phase. S4DX's technology records various parameters of blood samples during transport, offering real-time data integrated into laboratory systems. The company's solution is already deployed in twelve countries and is supported by partnerships with major players like Beckman Coulter, Roche, and Siemens Healthineers. S4DX is positioned for growth, having reached product-market fit and experiencing increasing demand from both customers and strategic partners. It is part of Katalysen's core investment portfolio, which emphasizes strong technology foundations and scaling potential. S4DX aims to enhance patient safety, reduce costs, and provide reliable diagnostics through its innovative platform.
Stockholmsbaserade QuTEM har nått ett viktigt steg i sitt uppdrag att förbättra kvaliteten och säkerheten hos nästa generations läkemedel. En ny studie i Molecular Therapy: Methods & Clinical Development visar att QuTEM:s innovativa elektronmikroskopiteknologi och bildanalys är en tillförlitlig och precis standard för att analysera byggstenarna i genterapi. I samarbete med Viralgen SL, en ledare inom tillverkning av genterapivektorer, har QuTEM:s metod visat sig vara mer tillförlitlig än flera etablerade tekniker, vilket pekar på dess potential som en ny standard för kvalitetskontroll inom genterapi. Josefina Nilsson, VD för QuTEM, noterar att erkännandet bekräftar QuTEM:s roll som en potentiell guldstandard för kvalitetskontroll inom genterapi, och att stora läkemedelsföretag har börjat outsourca en viktig del av sin kvalitetskontroll till QuTEM. Detta framhäver företagets växande relevans på en snabbt växande global marknad för genterapi, där efterfrågan på tillförlitliga kvalitetskontrollverktyg förväntas öka kraftigt. QuTEM:s metod erbjuder ett mer exakt sätt att skilja mellan fulla, delvis fyllda och tomma AAV-partiklar, och har utvecklats enligt internationella kvalitetsriktlinjer och opererar under ett GMP-certifikat från den svenska Läkemedelsverket. Deras metod är redan integrerad som en viktig kvalitetskontrollmätning och frigivningstest för genterapiprodukter, vilket stöder både bioteknikinnovatörer och stora läkemedelsföretag.
Sweden has over 400,000 unlisted and private companies, crucial for entrepreneurship, job creation, and innovation. However, these companies often face challenges due to outdated infrastructure, with ownership tracked in spreadsheets and inefficient fundraising processes. Alternativa, through its service eAktiebok, supports over 1,000 clients and aims to modernize this sector by scaling effective solutions, introducing new digital tools, and enhancing transparency and efficiency in the Swedish private company market. Led by CEO Martin N. Larsson, who has extensive experience in trading and finance, Alternativa is well-positioned to improve Sweden's private company infrastructure. With partners Katalysen and Apollonian, the company is working to create a modern ecosystem that facilitates efficient capital raising and clear governance for private companies. While currently focused on Sweden, Alternativa aims to expand internationally, addressing the global need for improved private company infrastructure. Tobias Mathiasen from Katalysen highlights three trends: increasing capital in unlisted companies, potential regulatory changes, and evolving fundraising infrastructure. These trends present opportunities for platforms like Alternativa to help unlisted companies adapt. Katalysen views Alternativa as a key investment, reflecting confidence in its potential to transform this sector. For more details on Katalysen Ventures, contact CEO Anders Dahlgren.
Under perioden 2024-06-05 till 2025-08-31 utnyttjades totalt 614'436 teckningsoptioner för att teckna 614'436 nya aktier i företaget, vilket motsvarar en teckningsgrad på 51,2 % av alla utfärdade optioner. Det finns för närvarande inga utestående optioner på Katalysens aktier, och alla nya aktier som utfärdats genom utnyttjande av optioner har registrerats hos Bolagsverket. Det totala antalet aktier i företaget är oförändrat sedan senast kommunicerat (9'115'826). För mer information om Katalysen Ventures, kontakta VD Anders Dahlgren via e-post: ad@katalysen.com eller besök www.katalysen.com.
Katalysen Ventures AB reported significant progress in the last quarter, highlighted by new Venture Targeter agreements and increased involvement with VALEGA Chain Analytics, resulting in doubled revenues for VALEGA in the first half of 2025 compared to 2024. The company added two new ventures, Syncro Group and Alternativa, to its portfolio, which will enhance value in the next quarter. Financially, Katalysen saw a 51% increase in revenue to SEK 0.8 million and a 45% reduction in operating losses compared to the previous year. Despite reducing valuations in four portfolio companies, the overall portfolio value rose from SEK 131 million to SEK 135 million. The company conducted a rights issue, raising approximately SEK 4.9 million to support operational initiatives. Katalysen remains focused on six key portfolio companies with strong potential and is preparing for potential asset sales and exits to strengthen liquidity and portfolio value. The company held its AGM, re-elected its auditor, and transitioned Peter Almberg to Executive Chairman, with Anders Dahlgren taking over as CEO. Important transactions and rights issues were completed, contributing to the overall strategic goals.

Threads

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: Katalysen Ventures AB publishes outcome of rights issue

Anders Dahlgren, CEO of Katalysen, expressed satisfaction with a 65 percent subscription rate for the company's Rights Issue, considering the current market conditions. The Rights Issue, which ended on July 8, 2025, involved a maximum of 1,400,988 shares, with 910,036 shares subscribed, equating to about 65 percent of the total offering. Of these, 28.1 percent were subscribed through subscription rights, and 8 percent without. The remaining shares were covered by a top guarantee. This outcome will moderate planned investments for the autumn, but operational plans remain unchanged. The share allocation followed principles outlined in a document from June 23, 2025, with payment instructions provided in settlement notes. After registration, the total shares will increase from 8,205,790 to 9,115,826, with a dilution effect of about 10 percent for non-participating shareholders. Peter Almberg's ownership will decrease from 10.2 percent to 9.6 percent. Trading in BTA will continue on the Spotlight Stock Market until registration, expected around July 21, 2025. Katalysen engaged several advisors for the Rights Issue. The press release includes legal disclaimers, emphasizing that it is not an offer or solicitation to buy securities, and highlights the forward-looking nature of some statements.

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: Katalysen Co-Founds Alternativa AB – Acquires Established Platform from Spotlight Group

Alternativa AB har tagit över en etablerad plattform med bevisad efterfrågan och en fungerande intäktsmodell. Företaget strävar efter att bli en ledande digital aktör inom aktieägaradministration och transaktioner för onoterade företag i Sverige, där det finns över 779,000 sådana företag. Plattformen eAktiebok erbjuder tjänster som digitala aktieböcker, en anslagstavla för köp- och säljintresse, och verktyg för att övervaka onoterade innehav. Alternativa planerar att utveckla nya funktioner som digitala emissioner och juridiska tjänster i samarbete med externa experter. Utvecklingen sker i nära dialog med marknaden. Martin N Larsson har utsetts till VD och har omfattande erfarenhet inom finanssektorn. Alternativa AB ägs gemensamt av Katalysen Ventures AB, Apollonian AG och Greenshoe Capital AB, och fokuserar på att erbjuda digitala verktyg för administration och finansiering av onoterade företag.

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: Katalysen medgrundar Alternativa AB – förvärvar etablerad plattform från Spotlight Group

Alternativa AB har tagit över en etablerad plattform med en fungerande intäktsmodell och växande kundbas, med målet att bli en ledande digital aktör inom ägaradministration och transaktioner för onoterade bolag. I Sverige finns över 779 000 onoterade aktiebolag, och Alternativa vill erbjuda dem enkla och effektiva digitala verktyg. Plattformen eAktiebok erbjuder funktioner som digital aktiebok, anslagstavla för köp- och säljintresse, verktyg för bevakning av onoterade innehav, digital kallelsehantering till bolagsstämmor, styrelserum online och marknadsföring av emissioner. Tjänsterna erbjuds i en anpassad abonnemangsmodell. Alternativa utvecklar också nya funktioner som digitala emissioner och IR-verktyg. Martin N Larsson, med över 20 års erfarenhet från finansbranschen, har utsetts till VD. Alternativa AB ägs av Katalysen Ventures AB, Apollonian AG och Greenshoe Capital AB och siktar på att bli en one-stop-shop för onoterade företag.

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: Last day to subscribe in Katalysen Ventures’ ongoing rights issue of shares

Katalysen Ventures AB is conducting a Rights Issue of 1,400,988 shares, aiming to raise approximately SEK 8.4 million before costs, with expected issue costs of SEK 1.0 million. Shareholders will receive seven subscription rights per share, and 41 rights allow for the purchase of one new share at SEK 6.0 each. The issue is partially secured by board members, management, and shareholders, covering about 48.5% of the total. The subscription period is from June 24 to July 8, 2025. No prospectus is provided; instead, a simplified information document is available. Trading in subscription rights is from June 24 to July 3, 2025, and trading in BTA will continue until the issue is registered. The outcome will be announced around July 9, 2025. Sedermera Corporate Finance AB, Foyen Advokatfirma i Sverige KB, and Nordic Issuing AB are advising on the issue. Legal restrictions apply to the distribution of this information in certain jurisdictions. The press release includes forward-looking statements that are subject to risks and uncertainties.

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: Katalysen genomför VT-affär i Syncro Group – nytt kapitel och tillväxtfokus

Syncro är ett teknologidrivet företag som erbjuder en AI-baserad lösning för influencer marketing, kombinerande konsulttjänster med en SaaS-plattform för effektiva kampanjer. Företaget bygger en stark marknadsposition genom partnerskap i Europa. Katalysens VD, Anders Dahlgren, uttrycker tilltro till Syncros potential och stödjer företagets transformation för att skapa långsiktigt värde. Syncro har genomfört en omstrukturering och fokuserar nu på tillväxt och internationell expansion, med Katalysen som stöd. Katalysen har förvärvat en del av Syncros aktier och teckningsoptioner och ser detta som början på en ny tillväxtfas. Katalysen har nu 23 innehav och kombinerar venture capital och private equity för att stödja entreprenörsledda företag i tillväxtfaser.

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: Katalysen completes VT transaction in Syncro Group – new chapter and growth focus

Syncro är ett teknikdrivet företag som erbjuder en AI-baserad lösning för influencer-marknadsföring. Företaget kombinerar konsulttjänster med en skalbar SaaS-plattform för att effektivisera kampanjer för varumärken och mediebyråer. Genom partnerskap med ledande byrågrupper i Europa stärker Syncro sin position på en växande marknad. Katalysen CEO Anders Dahlgren ser stor potential i Syncros erbjudande och tror att den nyligen avslutade omstruktureringen kommer att skapa långsiktigt värde. Katalysen har köpt cirka 1,5 procent av Syncros aktier och cirka 2 procent av TO9-optionerna. Investeringen är en del av Katalysens strategi för att stödja företag i tillväxtfaser. Katalysen har nu 23 innovationdrivna innehav i sin portfölj och kombinerar venturekapital och private equity för att stödja entreprenörsledda företag.

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: The subscription period in Katalysen Ventures’ rights issue of shares begins today

Katalysen Ventures AB is launching a rights issue of shares to raise approximately SEK 8.4 million, with a subscription period from June 24 to July 8, 2025. Existing shareholders will have preferential rights, with a subscription price set at SEK 6.0 per share. The rights issue is partially secured by board members and existing investors, covering about 48.5% of the total amount. An overallotment issue may be used to raise an additional SEK 3.0 million if the rights issue is oversubscribed. The company aims to strengthen its capital base to finance new investments, support portfolio companies, and maintain operational capacity amid a challenging economic environment. Katalysen has shifted its strategy to focus on mature companies facing complex challenges and seeks to accelerate growth through high-quality transactions. The rights issue could result in a dilution effect of approximately 14.6% for non-participating shareholders. Trading in subscription rights will occur from June 24 to July 3, 2025. A simplified information document is available online, and no prospectus will be prepared.

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: Katalysen Ventures AB publishes information document in connection with the rights issue

Katalysen Ventures AB has announced a share issue with preferential rights for existing shareholders, aiming to raise approximately SEK 8.4 million at a subscription price of SEK 6.0 per share. In case of oversubscription, the company may also initiate an Overallotment Issue to raise an additional SEK 3.0 million. No prospectus has been prepared; instead, a simplified information document is available on the company's website. The Rights Issue is supported by board members, management, and existing shareholders, covering about 48.5% of the issue through subscription and guarantee commitments. The record date is set for June 23, 2025, with a subscription period from June 24 to July 8, 2025. Sedermera Corporate Finance AB, Foyen Advokatfirma i Sverige KB, and Nordic Issuing AB are advising on the process. The press release includes disclaimers about legal restrictions and forward-looking statements, emphasizing that the information provided is not exhaustive and subject to change.

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: Katalysen Ventures AB carries out rights issue of approximately SEK 8.4 million

Peter Almberg, Chairman, and Anders Dahlgren, CEO, of Katalysen Ventures AB discuss the company's strategic direction and upcoming rights issue. They express optimism about offering shareholders a chance to participate in the company's next phase, which includes exits, improved cash flow, and new deals. The rights issue involves issuing 1,400,988 shares at SEK 6.0 per share, aiming to raise approximately SEK 8.4 million. It is secured by 48.5% through commitments from board members, management, and existing shareholders. The subscription period runs from June 24 to July 8, 2025. The funds will support new investments, operational capacity, and exit opportunities. Katalysen has shifted focus to mature, founder-led companies and sees potential in the current macroeconomic environment. An Overallotment Issue may be used if the rights issue is oversubscribed. The company will publish an information document before the subscription period begins.

Spotlight News profile image

Spotlight News

Nyhetsuppdatering från Katalysen Ventures

Press release from Companies: Katalysen Ventures AB: Increase to total shares in company following early exercise of warrants

Antalet aktier i Katalysen Ventures AB har ökat med 251 765 efter att optionsinnehavare utnyttjat sina teckningsoptioner. Det totala antalet aktier är nu 8 205 790. För mer information kan man kontakta VD Anders Dahlgren via e-post eller besöka företagets webbplats.